These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2656706

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.
    Guo XY, Cuillerot JM, Wang T, Wu Y, Arlinghaus R, Claxton D, Bachier C, Greenberger J, Colombowala I, Deisseroth AB.
    Oncogene; 1998 Aug 20; 17(7):825-33. PubMed ID: 9779999
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor.
    Izuhara K, Feldman RA, Greer P, Harada N.
    J Biol Chem; 1994 Jul 15; 269(28):18623-9. PubMed ID: 7518439
    [Abstract] [Full Text] [Related]

  • 27. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
    Hjermstad SJ, Briggs SD, Smithgall TE.
    Biochemistry; 1993 Oct 05; 32(39):10519-25. PubMed ID: 7691175
    [Abstract] [Full Text] [Related]

  • 28. Expression pattern of c-fes oncogene mRNA in human myeloid cells.
    Lanfrancone L, Mannoni P, Pebusque MJ, Carè A, Peschle C, Grignani F, Pelicci PG.
    Int J Cancer Suppl; 1989 Oct 05; 4():35-8. PubMed ID: 2681011
    [No Abstract] [Full Text] [Related]

  • 29. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
    Cheng HY, Schiavone AP, Smithgall TE.
    Mol Cell Biol; 2001 Sep 05; 21(18):6170-80. PubMed ID: 11509660
    [Abstract] [Full Text] [Related]

  • 30. Expression of two myeloid cell-specific genes requires the novel transcription factor, c-fes expression factor.
    Heydemann A, Boehmler JH, Simon MC.
    J Biol Chem; 1997 Nov 21; 272(47):29527-37. PubMed ID: 9368014
    [Abstract] [Full Text] [Related]

  • 31. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
    Lindner I, Kharfan-Dabaja MA, Ayala E, Kolonias D, Carlson LM, Beazer-Barclay Y, Scherf U, Hnatyszyn JH, Lee KP.
    J Immunol; 2003 Aug 15; 171(4):1780-91. PubMed ID: 12902478
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation.
    Manfredini R, Grande A, Tagliafico E, Barbieri D, Zucchini P, Citro G, Zupi G, Franceschi C, Torelli U, Ferrari S.
    J Exp Med; 1993 Aug 01; 178(2):381-9. PubMed ID: 8340750
    [Abstract] [Full Text] [Related]

  • 33. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
    Cheng H, Rogers JA, Dunham NA, Smithgall TE.
    Mol Cell Biol; 1999 Dec 01; 19(12):8335-43. PubMed ID: 10567558
    [Abstract] [Full Text] [Related]

  • 34. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein.
    MacDonald I, Levy J, Pawson T.
    Mol Cell Biol; 1985 Oct 01; 5(10):2543-51. PubMed ID: 2426571
    [Abstract] [Full Text] [Related]

  • 35. The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained protein-tyrosine kinase activity.
    Greer PA, Meckling-Hansen K, Pawson T.
    Mol Cell Biol; 1988 Feb 01; 8(2):578-87. PubMed ID: 3352601
    [Abstract] [Full Text] [Related]

  • 36. Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation.
    Mahdi T, Alcalay D, Cognard C, Tanzer J, Kitzis A.
    Biol Cell; 1998 Dec 01; 90(9):615-27. PubMed ID: 10085538
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
    Ogawa K, Tashima M, Toi T, Sawai H, Sawada H, Fujita J, Maruyama Y, Okuma M.
    Exp Hematol; 1994 Jan 01; 22(1):45-51. PubMed ID: 7506674
    [Abstract] [Full Text] [Related]

  • 38. Activation of STAT3 by the c-Fes protein-tyrosine kinase.
    Nelson KL, Rogers JA, Bowman TL, Jove R, Smithgall TE.
    J Biol Chem; 1998 Mar 20; 273(12):7072-7. PubMed ID: 9507017
    [Abstract] [Full Text] [Related]

  • 39. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R, O'Bryan E, Huang M, Bali P, Burnette PK, Loughran T, Tepperberg J, Jove R, Bhalla K.
    Cancer Res; 2002 Oct 15; 62(20):5761-9. PubMed ID: 12384536
    [Abstract] [Full Text] [Related]

  • 40. Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells.
    Hackenmiller R, Simon MC.
    Dev Biol; 2002 May 15; 245(2):255-69. PubMed ID: 11977979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.